Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging Gene Therapeutics for Epidermolysis Bullosa under Development.

International journal of molecular sciences - 13 Feb 2024

Bischof Johannes, Hierl Markus, Koller Ulrich

Abstract excerpt

The monogenetic disease epidermolysis bullosa (EB) is characterised by the formation of extended blisters and lesions on the patient's skin upon minimal mechanical stress. Causal for this severe condition are genetic mutations in genes, leading to the functional impairment, reduction, or absence of the encoded protein within the skin's basement membrane zone connecting the epidermis to the underlying dermis. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blister
Share to Epidermis
Share to Epidermolysis Bullosa

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 38396920
DOI: 10.3390/ijms25042243
PMCID: PMC10889532

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging Gene Therapeutics for Epidermolysis Bullosa under Development.PMID 38396920Read ↗

Treatment of Epidermolysis Bullosa and Future Directions: A ReviewSemantic proximity Read ↗

Recent advances in understanding and managing epidermolysis bullosaSemantic proximity Read ↗

Current Treatment Landscape for Dystrophic Epidermolysis Bullosa: From Surgical Management to Emerging Gene Therapies and Novel Skin GraftsSemantic proximity Read ↗

Stairways to Advanced Therapies for Epidermolysis Bullosa.Semantic proximity Read ↗

Newer treatment modalities in epidermolysis bullosaSemantic proximity Read ↗

Epidermolysis bullosa: scientific advances and therapeutic challenges.Semantic proximity Read ↗

EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure.Semantic proximity Read ↗

Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 2020.Semantic proximity Read ↗

Therapies for genetic extracellular matrix diseases of the skin.Semantic proximity Read ↗

Progress in skin gene therapy: From the inside and outSemantic proximity Read ↗

Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosaSemantic proximity Read ↗

[Hereditary blistering diseases. Symptoms, diagnosis and treatment of epidermolysis bullosa].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.